ANR Stock Discussion
Anatara Lifesciences Ltd Description
Anatara Lifesciences Ltd is an Australia-based company focused on developing oral solutions for gastrointestinal diseases in production animals and humans and the development and commercialization of Detach, a non-antibiotic therapy that prevents and treats diarrhea (scour) in piglets. Detach is a modified release formulation of BromelainRx, a natural extract from pineapple stems. Detach helps in address the overuse of antibiotics in animals. It is formulated with various ingredients to allow oral administration and delivery to the small intestine. The Company is focused on developing Detach for pigs in Australia and then expanding the program to Europe and the United States. The Company is also developing a similar version of Detach to prevent diarrhea in humans. The Company is seeking to collaborate with pharmaceutical/biotechnology companies for clinical development and commercialization of a similar version of Detach for human application in travelers and military personnel.
Industry: Biotechnology
Keywords: Health Gas Medicine Pharmaceutical Biotechnology Disease Travel Diseases Medical Specialties Therapy Pharmaceuticals Policy Animals Military Antibiotic Humans Inr Antibiotics Biotechnology Companies Sanitation Veterinary Medicine Digestive System
Recent Comments
- SwingTradeBot on Market Recap for Wednesday, February 28, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
- SwingTradeBot on Market Recap for Monday, February 26, 2024
- SwingTradeBot on Market Recap for Friday, February 23, 2024
- SwingTradeBot on Market Recap for Thursday, February 22, 2024
From the Blog
Featured Articles